Status:
RECRUITING
Evaluation of muLtimodal and Non-invasive SPINa Bifida Neurovessels During Prospective Follow-up
Lead Sponsor:
Rennes University Hospital
Collaborating Sponsors:
NeuroSphinx
Conditions:
Spina Bifida
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
The aim of the study is to investigate known urinary biomarkers in order to determine whether they can be predictive of a risk of damage to the upper urinary tract and therefore the kidneys in patient...
Eligibility Criteria
Inclusion
- Spina patients consulted as part of the multidisciplinary consultation of the spina bifida rare disease reference centre;
- Written consent to participate in the research.
- Compulsory membership of a social security scheme
Exclusion
- Patients with a non-continuous trans ileal urinary diversion ;
- Patients with enterocystoplasty;
- Untreated bacteriuria at the time of urodynamic assessment and urine sample collection;
- History of urinary tract tumour;
- History of histologically proven interstitial cystitis;
- Persons under legal protection (safeguard of justice, curatorship, guardianship);
- Persons deprived of their liberty.
- Women claiming to be pregnant
Key Trial Info
Start Date :
January 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 18 2028
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06041334
Start Date
January 18 2024
End Date
July 18 2028
Last Update
December 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rennes University Hospital
Rennes, CHU de Rennes, France, 35033